Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
42.89
-1.22 (-2.77%)
Mar 19, 2026, 3:00 PM CST

SHA:600211 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,9822,8003,1282,5452,127
Other Revenue
-6.736.249.6912.06
2,9822,8073,1342,5552,139
Revenue Growth (YoY)
6.23%-10.45%22.69%19.45%55.75%
Cost of Revenue
172.47162.1158.67204.74225.8
Gross Profit
2,8092,6452,9762,3501,913
Selling, General & Admin
1,7741,6851,8811,5411,254
Research & Development
74.0828.9417.3588.1360.86
Other Operating Expenses
-8.4737.138.1732.5426.2
Operating Expenses
1,8391,7511,9371,6621,340
Operating Income
969.91893.441,039688.27572.75
Interest Expense
--9.48-11.59-14.36-4.33
Interest & Investment Income
7.4874.3886.2221.352.67
Currency Exchange Gain (Loss)
--2.47-0.11-3.83-4.78
Other Non Operating Income (Expenses)
66.3-0.17-0.47-0.39-0.35
EBT Excluding Unusual Items
1,044955.691,113691.03565.96
Gain (Loss) on Sale of Investments
1.66-18.99-210.53-14.17146.47
Gain (Loss) on Sale of Assets
0.111.90.34-0.23-0.17
Asset Writedown
-4.85--190.38-218.62-458.06
Other Unusual Items
-213.48186.035.360.64
Pretax Income
1,0411,152898.19463.39254.85
Income Tax Expense
123.6495.0187.9588.0841.82
Earnings From Continuing Operations
916.981,057810.24375.31213.03
Minority Interest in Earnings
20.95-5.79-9.33-5.47-4.09
Net Income
937.931,051800.91369.84208.94
Net Income to Common
937.931,051800.91369.84208.94
Net Income Growth
-10.78%31.26%116.56%77.01%-50.03%
Shares Outstanding (Basic)
322322323323323
Shares Outstanding (Diluted)
322322323323323
Shares Change (YoY)
-0.05%-0.14%0.09%-0.21%0.53%
EPS (Basic)
2.913.262.481.150.65
EPS (Diluted)
2.913.262.481.150.65
EPS Growth
-10.74%31.45%116.37%77.38%-50.29%
Free Cash Flow
988.79957.191,042735.41-59.05
Free Cash Flow Per Share
3.072.973.232.28-0.18
Dividend Per Share
-1.9571.4920.5740.260
Dividend Growth
-31.21%159.93%120.69%-33.72%
Gross Margin
94.22%94.23%94.94%91.98%89.44%
Operating Margin
32.53%31.83%33.14%26.94%26.78%
Profit Margin
31.46%37.46%25.55%14.48%9.77%
Free Cash Flow Margin
33.16%34.10%33.24%28.79%-2.76%
EBITDA
1,049967.641,107757.52654.2
EBITDA Margin
35.20%34.48%35.31%29.65%30.59%
D&A For EBITDA
79.5574.268.0569.2481.45
EBIT
969.91893.441,039688.27572.75
EBIT Margin
32.53%31.83%33.14%26.94%26.78%
Effective Tax Rate
11.88%8.25%9.79%19.01%16.41%
Revenue as Reported
---2,5552,139
Advertising Expenses
-6.232.220.050.24
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.